http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102532097-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33a62710796e131599043055d399597f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20
filingDate 2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d50423d6735f191f691c60781af1507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8febd2e07e9b39a222fe21355213897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0efdd148c7f40d062f98f49aaf39e2b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_989798d60c31080cf0abafe70c9d7620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d25b87202c207e913db9cb3de92e6b23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41737a06fdfaa499852542a89972bf0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da826c264bb55a672358b98d35914dca
publicationDate 2012-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102532097-A
titleOfInvention Asymmetric synthesis method of duloxetine intermediate-(S)-N,N-dimethyl-3-hydroxyl-3-(2-thienyl)-1-propanamine
abstract The invention provides an asymmetric synthesis method of (S)-N,N-dimethyl-3-hydroxyl-3-(2-thienyl)propylamine, the main step of which is (R)-(+)-α , α-diaryl prolinol or (R)-(+)-α, α-diaryl prolinol silicon ether is used as a catalyst, and metal hydride complexes such as sodium borohydride and potassium borohydride are used for reduction Reagent, reduced to (S)-N, N-dimethyl-3-hydroxyl-3-(2-thienyl) propylamine. The method is simple and feasible, has high yield and optical purity, and is suitable for large-scale production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104744266-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104744266-A
priorityDate 2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101384532-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433065513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154451107

Total number of triples: 21.